Bloom DM - Search Results

1

Cholecystokinin peptides, dopamine and schizophrenia--a review.

Nair NP, Lal S, Bloom DM. Nair NP, et al. Among authors: bloom dm. Prog Neuropsychopharmacol Biol Psychiatry. 1985;9(5-6):515-24. doi: 10.1016/0278-5846(85)90011-9. Prog Neuropsychopharmacol Biol Psychiatry. 1985. PMID: 2868491 Review.

2

Cholecystokinin-octapeptide in chronic schizophrenia: a double-blind placebo-controlled study.

Nair NP, Bloom DM, Debonnel G, Schwartz G, Mosticyan S. Nair NP, et al. Among authors: bloom dm. Prog Neuropsychopharmacol Biol Psychiatry. 1984;8(4-6):711-4. doi: 10.1016/0278-5846(84)90043-5. Prog Neuropsychopharmacol Biol Psychiatry. 1984. PMID: 6152344 Clinical Trial.

3

Cholecystokinin appears to have antipsychotic properties.

Nair NP, Bloom DM, Nestoros JN. Nair NP, et al. Among authors: bloom dm. Prog Neuropsychopharmacol Biol Psychiatry. 1982;6(4-6):509-12. doi: 10.1016/s0278-5846(82)80140-1. Prog Neuropsychopharmacol Biol Psychiatry. 1982. PMID: 6891817

4

Cholecystokinin and schizophrenia.

Nair NP, Lal S, Bloom DM. Nair NP, et al. Among authors: bloom dm. Prog Brain Res. 1986;65:237-58. doi: 10.1016/S0079-6123(08)60654-8. Prog Brain Res. 1986. PMID: 3538160 Review. No abstract available.

5

Verapamil in the treatment of chronic schizophrenia.

Tourjman SV, Bloom DM, Nair NP. Tourjman SV, et al. Among authors: bloom dm. Psychopharmacol Bull. 1987;23(1):227-9. Psychopharmacol Bull. 1987. PMID: 3602324 No abstract available.

6

Verapamil in refractory schizophrenia: a case report.

Bloom DM, Tourjman SV, Nair NP. Bloom DM, et al. Prog Neuropsychopharmacol Biol Psychiatry. 1987;11(2-3):185-8. doi: 10.1016/0278-5846(87)90058-3. Prog Neuropsychopharmacol Biol Psychiatry. 1987. PMID: 3628827

7

Clinical and neuroendocrine studies with cholecystokinin peptides.

Nair NP, Bloom D, Lal S, Debonnel G, Schwartz G, Mosticyan S. Nair NP, et al. Ann N Y Acad Sci. 1985;448:535-41. doi: 10.1111/j.1749-6632.1985.tb29946.x. Ann N Y Acad Sci. 1985. PMID: 2862831 No abstract available.

8

High doses of diazepam improve neuroleptic-resistant chronic schizophrenic patients.

Nestoros JN, Nair NP, Pulman JR, Schwartz G, Bloom D. Nestoros JN, et al. Psychopharmacology (Berl). 1983;81(1):42-7. doi: 10.1007/BF00439272. Psychopharmacology (Berl). 1983. PMID: 6138791

9

Dopamine beta-hydroxylase (DBH) gene and schizophrenia phenotypic variability: a genetic association study.

Yamamoto K, Cubells JF, Gelernter J, Benkelfat C, Lalonde P, Bloom D, Lal S, Labelle A, Turecki G, Rouleau GA, Joober R. Yamamoto K, et al. Am J Med Genet B Neuropsychiatr Genet. 2003 Feb;117B(1):33-8. doi: 10.1002/ajmg.b.10011. Am J Med Genet B Neuropsychiatr Genet. 2003. PMID: 12555232

10

Association between the methylenetetrahydrofolate reductase 677C-->T missense mutation and schizophrenia.

Joober R, Benkelfat C, Lal S, Bloom D, Labelle A, Lalonde P, Turecki G, Rozen R, Rouleau GA. Joober R, et al. Mol Psychiatry. 2000 May;5(3):323-6. doi: 10.1038/sj.mp.4000724. Mol Psychiatry. 2000. PMID: 10889537

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters